Similar companies
Company | Transaction Value | |
---|---|---|
OcugenOCGN |
-$4.6M | |
AmarinAMRN |
$1.7M | |
Gilead SciencesGILD |
-$254M | |
Anavex Life SciencesAVXL |
-$14M | |
Inovio PharmaceuticalsINO |
-$2.2M |
Insider Transactions
Name | Transaction Date | Sold / Bought | Shares | Price | Value |
---|---|---|---|---|---|
Opaleye Management Inc. | Dec 31, 2024 | Buy | 10,000 | $4.6603 | $47,000 |
Opaleye Management Inc. | Dec 30, 2024 | Buy | 35,000 | $4.6969 | $160,000 |
Opaleye Management Inc. | Oct 25, 2024 | Buy | 25,000 | $2.9088 | $73,000 |
Opaleye Management Inc. | Sep 25, 2024 | Buy | 5,000 | $2.8581 | $14,000 |
Opaleye Management Inc. | Sep 24, 2024 | Buy | 80,000 | $2.9357 | $230,000 |
Opaleye Management Inc. | Sep 23, 2024 | Buy | 45,000 | $2.9441 | $130,000 |
Opaleye Management Inc. | Sep 20, 2024 | Buy | 1,010,000 | $3.01 | $3M |
Opaleye Management Inc. | Sep 18, 2024 | Buy | 55,000 | $3.1638 | $170,000 |
Opaleye Management Inc. | Sep 18, 2024 | Buy | 6,000 | $3.1638 | $19,000 |
Dorgan Byron L | Nov 15, 2023 | Sell | 20,000 | $2.1084 | $42,000 |
Norrett Kevin | Sep 11, 2023 | Buy | 9,000 | $1.7199 | $15,000 |
Ryali Sriram | Sep 8, 2023 | Buy | 11,650 | $1.7044 | $20,000 |
Fitzgerald Margaret Nell | Sep 8, 2023 | Buy | 11,834 | $1.6955 | $20,000 |
DILLY STEPHEN GEORGE | Sep 8, 2023 | Buy | 58,479 | $1.7263 | $100,000 |
NICOLS JOHN J | Apr 18, 2023 | Sell | 35,714 | $4.1405 | $150,000 |
NICOLS JOHN J | Mar 16, 2023 | Sell | 35,714 | $4.1071 | $150,000 |
DILLY STEPHEN GEORGE | Mar 8, 2023 | Sell | 26,987 | $4.5552 | $120,000 |
Norrett Kevin | Mar 8, 2023 | Sell | 8,258 | $4.5552 | $38,000 |
Fitzgerald Margaret Nell | Mar 8, 2023 | Sell | 7,686 | $4.5552 | $35,000 |
DILLY STEPHEN GEORGE | Mar 7, 2023 | Sell | 28,088 | $4.6027 | $130,000 |
Norrett Kevin | Mar 7, 2023 | Sell | 8,596 | $4.6027 | $40,000 |
Fitzgerald Margaret Nell | Mar 7, 2023 | Sell | 8,000 | $4.6027 | $37,000 |
NICOLS JOHN J | Feb 24, 2023 | Sell | 35,714 | $4.8343 | $170,000 |
NICOLS JOHN J | Feb 23, 2023 | Sell | 39,785 | $5.3593 | $210,000 |
NICOLS JOHN J | Jan 24, 2023 | Sell | 35,714 | $6.4203 | $230,000 |
NICOLS JOHN J | Jan 23, 2023 | Sell | 39,785 | $6.5764 | $260,000 |
What's the latest insider transaction for Codexis?
The most recent insider transaction for Codexis was conducted by Opaleye Management Inc., who sold 10,000 shares on December 31, 2024 at a price of $4.66 per share.
Which insider bought the most CDXS stock over the last two years?
Opaleye Management Inc. has bought the most CDXS stock in the last 2 years, with a total value of $3.9M.
Which insider has sold the most CDXS stock over the last two years?
NICOLS JOHN J has sold the most CDXS stock in the last 2 years, with a total value of $1.2M.
What is the total value of insider transactions for Codexis (CDXS) in the last 2 years?
According to our estimates, the total value of insider transactions for Codexis in the last 2 years is positive, amounting to $2.4M. This indicates that insiders have predominantly bought shares, showcasing their confidence in the company's future prospects.
How do insider transactions over the last 2 years reflect on Codexis' market confidence?
Over the last 2 years, insider transactions for Codexis have been balanced between buying and selling, showing a neutral stance among insiders towards the company's market performance. This trend of more purchases than sales could be a positive signal to potential investors about the insiders' view on the company's valuation and growth potential.
Why is monitoring insider trading activity important for investors?
Monitoring insider trading activity is important because it provides insights into the confidence levels of a company's insiders, such as executives and directors, regarding the company's future prospects. Insider buying can signal optimism, suggesting the stock may be undervalued, while insider selling might raise questions about the stock's upcoming performance. However, it's essential to consider that sales can also occur for personal financial reasons. Insider trading activity is a valuable indicator that, when combined with other data, can help inform investment decisions.